SNT
Click for more information
0.00% 3.5¢ syntara limited

Ann: Pharmaxis Drug Study Published in Nature Communications, page-2

  1. Sirbrighton
    396 Posts.
    lightbulb Created with Sketch. 79
    clock Created with Sketch.
    23/03/23
    10:12
    Post #: 66915632
    This is a very promising treatment development and a good milestone achieved. The progress should not go unnoticed by the media and health and pharma sectors generally.
    PXS Price at posting: 4.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Dale Gillham's weekly wrap: responding to a weak iron ore price with investing decisions
right-arrow Created with Sketch.
NEWS Talking trends: The five shaping investment in 2024
right-arrow Created with Sketch.
RDN Raiden gears up for exploration in final quarter of 2024
right-arrow Created with Sketch.
KPO KALiNA Power inks MOU for natgas powered data centres using carbon capture as AI energy use grows
right-arrow Created with Sketch.
NEWS HotCopper's top watched; Oz banks cut saver interest; Kamala’s 28% corporate tax; AI’s back
right-arrow Created with Sketch.
NEWS The business of sport: Warren Tredrea's take on this week's news
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $45.16M
Open High Low Value Volume
3.6¢ 3.6¢ 3.3¢ $58.54K 1.668M

Buyers (Bids)

No. Vol. Price($)
1 5226 3.5¢
 

Sellers (Offers)

Price($) Vol. No.
3.6¢ 969288 2
View Market Depth
Last trade - 16.10pm 27/08/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.